Summary:
An efficient and stereocontrolled synthesis of hydroxyethylene dipeptide isosteres 1 from commercially available, optically pure D-mannose is described. This synthesis represents a practical and enantioselective entry to a range of other dipeptide isosteres, which are not limited to amino acid derived substituents.
Since the advent of acquired immunodeficiency syndrome (AIDS) and the discovery of its causative agent, human immunodeficiency virus (HIV-l),1 the design and synthesis of mechanism-based HIV-1 protease inhibitors has intensified tremendously. The HIV-1 protease, an aspartic protease, is a proteolytic enzyme that cleaves the gag and gag-pol precursor polyproteins into the functional proteins of infectious virus particles2 In vitro disruption of this protease-dependent processing step results in the production of protease-defective virions which are immature and noninfectious.3 Therefore, therapeutic intervention of this enzyme represents a powerful strategy for the treatment of AIDS and related ailments.
Recently, we4 and others5 have reported a series of potent and selective HIV-1 protease inhibitors which are designed based on the transition-state mimetic concept.6 This approach incorporates the natural amino acid statine7 and hydroxyethylene dipeptide isostere8,9 at the scissile site, an approach that has been successfully utilized in the design and synthesis of potent inhibitors of renin10 and other aspartic proteases.11 Since the first synthesis of hydroxyethylene dipeptide mimics, by Szelke8 and Rich9 in 1983, several other syntheses of dipeptide isosteres have appeared in the literature.12 The majority of previous syntheses, however, have limitations with regard to stereochemical controls and variations of the substituents at C-2 and C-5 positions. In connection with the synthesis of potent and selective inhibitors of HIV-1 protease, we required an efficient, flexible and enantioselective synthesis of hydroxyethylene dipeptide mimics which were not limited to amino acid derived substituents. We describe here a new synthesis of Phe-Phe isostere 1 through the inter-mediacy of lactone 2, with absolute stereocontrol at the C-4 and C-5 positions, utilizing commercially available and optically pure D-mannOSe as starting material. This synthesis is potentially versatile and represents a practical and enantioselective entry to other dipeptide isosteres with a wide variety of substituents at C-2 and C-5 positions.

As shown in Scheme I, optically active D-mannose presents a unique opportunity for the synthesis of enantiomerically pure Phe-Phe dipeptide isostere 1 and related analogues. D-Mannose 3 already possesses the C-4 hydroxy group of hydroxyethylene isostere 1 with appropriate absolute configuration. Synthesis of isosteric lactone 2 requires deoxygenation of the C-2 and C-3 hydroxy groups, incorporation of phenyl and benzyl groups at C-6 and C-2, and introduction of nitrogen with inversion of configuration at C-5. Thus, D-mannOSe 3 was converted to 2,3:5,6-di-O-isopropylidene-α-D-mannofuranose 4 according to the reported procedure of Freudenberg.13 Required deoxygenation of 4 at the C-2 position was readily achieved utilizing Ireland’s procedure.14 Ãccordingly, reaction of mannofuranose 4 with carbon tetrachloride (1.2 equiv) and tris(dimethy1amino)phosphine (1.2 equiv) in tetrahydrofuran (−78 °C for 30 min and then 23 °C for 30 min) and subsequent reduction of the resulting furanosyl chloride with lithium in liquid ammonia at −78 to 0 °C for 5 h afforded the glycal 5 (72% yield) along with a small amount of dehalogenation byproduct 6 (3% yield) after flash chromatography over silica gel. Although the reduction of furanosyl chloride with di-tert-butylbiphenyl radical anion resulted in 5 in excellent yield (85%), use of lithium in liquid ammonia was found to be operationally more convenient for large-scale preparation.
Scheme Ia.
aReagents: (a) Me2C0, 3%H2SO4, 23 °C, 12 h; (b) CC14, (Me2N)3,P, THF, −78 to 23 °C, 1 h; then Li, NH3, −78 to 0 °C, 5 h; (c) MeOH, PPTS, CH2C12, 0–23 °C, 12 h; (d) 10% Pd-C, H2, Et-OAC-MeOH (4:1), 5 h; (e) 40% aqueous AcOH, 90 °C, 3 h; (f) p-TsCl, pyridine, 0–23 °C, 12 h; (g) NaOMe, CHCl3, 0 °C for 10 min; then 23 °C, 4 h; (h) PhMgBr, CUI, THF, −40 to 0 °C, 3 h; (i) Ph3P, EtO2CN=NCO2Et, Ph2P(O)N3, PhMe, −10 to 23 °C, 12 h.
Further dehydroxylation of glycal 5 at the C-3 position was efficiently carried out employing Ferrier-type rear-rangement15 with methanol in the presence of pyridinium p-toluenesulfonate in methylene chloride (0–23 °C for 12 h) to provide a mixture (52:48 by 1H NMR) of methyl glycoside 7 in 97% isolated yield. Reaction of 5 with 2-propanol in methylene chloride in the presence of p-toluenesulfonic acid at 0 °C or stannic chloride promoted reaction at −78 °C offered no enhancement of the anomeric effect;l6 the ratio of anomers remained the same (1:l) after workup. Since the methyl glycoside 7 would eventually be converted to the corresponding γ-lactone, all subsequent reactions were carried out with the mixture of anomers. Catalytic hydrogenation of 7 with 10% palladium on charcoal under atmospheric pressure in 4:l ethyl acetate-methanol afforded the corresponding saturated glycoside in quantitative yield. Removal of the isopropylidene group was then effected by heating the resulting glycoside with 40% aqueous acetic acid at 90 °C for 3 h, followed by evaporation of solvents under reduced pressure and silica gel chromatography provided diol 8 (84% yield). Glycosidic diol 8 was then converted to the desired epoxide 9 in the following two-step sequence: (1) selective O-tosylation of the primary alcohol with p-toluenesulfonyl chloride (1.1 equiv) in pyridine at 0 °C for 12 h and (2) treatment of the resulting crude tosylate with sodium methoxide (5 equiv) in chloroform at 23 °C for 4 h to provide the epoxide 9 in 72% yield after silica gel chromatography. Regiospecific epoxide ring opening of 9 with phenylmagnesium bromide (2.2 equiv) in the presence of cuprous iodide (1.1 equiv) at −40 to 0 °C for 3 h afforded glycosidic alcohol 10 in 91 % yield after flash chromatography over silica gel. Thus, nucleophilic opening of epoxide 9 allows the incorporation of a variety of substituents at the C-5 position, an option not afforded by previous syntheses of hydroxyethylene isosteres.
Conversion of glycosidic alcohol 10 to the corresponding azide 11 was readily accomplished by a Mitsunobu reaction.17 Thus, reaction of 10 with triphenylphosphine (1.2 equiv), diethyl azodicarboxylate (1.2 equiv), and diphenylphosphoryl azide (1.2 equiv) in toluene at −10 to 23 °C for 12 h furnished the azide 11 (92% yield) along with a small amount (<3%) of elimination product. Interestingly, formation of the mesylate of 10 with masy1 chloride in pyridine and subsequent displacement of the mesylate with sodium azide in DMF at 90 °C or tetramethylguanidinium azide in DMF at 80 °C resulted in 11 (65–70% yield) and 15–20% elimination product resulting from E2 reaction. Grieco oxidation18 of methyl furanoside 11 with m-chloroperbenzoic acid (1.2 equiv) in dry methylene chloride at 0 °C for 3 h in the presence of boron trifluoride etherate (0.25 equiv) afforded the corresponding azido γ-lactone in 72% yield after silica gel chromatography. Catalytic hydrogenation19 of the resulting azido lactone with 10% palladium on charcoal in the presence of di-tert-butyl dicarbonate for 6 h furnished the tert-butyloxycarbonyl-protected amino lactone 12 (white solid, mp 95 °C) exclusively in 91 % yield. The γ-lactone 12 is a versatile intermediate for the synthesis of suitably substituted hydroxyethylene dipeptide isosteres.
Introduction of a benzyl group at C-2 was accomplished by stereoselective alkylation12b of 12 with benzyl halide. Thus, generation of the dianion of lactone 12 with lithium hexamethyldisilazide (2.2 equiv) in tetrahydrofuran at −78 °C (30 min) and alkylation with benzyl iodide (1.1 equiv) for 30 min at −78 °C, followed by quenching with propionic acid (5 equiv), provided the desired alkylated lactone 2 (84% yield, mp 76–78 °C) along with a small amount (<4% by HPLC) of undesired cis isomer 13 (mp 112–115 °C). The minor cis lactone was conveniently removed by column chromatography over silica gel using a mixture (1:l) of ethyl acetate-hexanes as the solvent system. The stereochemical assignment of alkylated lactones 2 and 13 were made based on extensive 1H NMR NOE experiments as well as by comparison of 1H NMR spectra with that reported previously.12 Weinreb amidation20 of lactone 2 with benzylamine (2 equiv) and trimethylaluminum (2 equiv) in methylene chloride (23 °C for 10 min, then 40 °C for 3 h) afforded hydroxyamide 14 (74% yield, mp 179–182 °C) after silica gel chromatography.21 Lactone 2 was converted to potent and selective inhibitors of HIV-1 protease according to the previous literature procedure.4
In conclusion, an efficient, stereocontrolled, and economical synthetic route to dipeptide isostere 1 has been developed. Since the starting material of this synthesis is D-mannose rather than an amino acid, the present methodology should provide convenient access to other dipeptide isosteres with a great deal of structural diversity at C-2 and C-5 positions. Synthesis of a number of HIV-1 protease inhibitors containing hydroxyethylene isosteres and their biological evaluation is currently under investigation.
Supplementary Material
Scheme IIa.
aReagents: (j) MCPBA, BF3.OEt2, CH2Cl2, 0 °C, 3 h; (k) 10% Pd-C, H2, EtOAc, BOC2O, 6 h; (1) (TMS)2NLi, THF, −78 °C, 30 min; PhCH2I, −78 °C, 30 min; then MeCH2CO2H, −78 to 23 °C, 15 min; (m) Me3A1, PhCH2NH2, CH2C12, 40 °C, 3 h.
Acknowledgment.
The authors thank professor Samuel Danishefsky for helpful discussions and acknowledge the encouragement and support of Dr. Joel R. Huff and Dr. Paul S. Anderson.
Footnotes
Supplementary Material Available:
Experimental procedures and spectral data for compounds 5–14 (7 pages). Ordering information is given on any current masthead page.
References
- (1).(a) BarreSinouesi F; Chermann JC; Rey F; Nugeyre MT; Chamaret S; Gruest J; Dauguet C; Axler-Blin C; Vezinet-Brun F; Rouzioux C; Rozenbaum W; Montagnier L Science 1983,220,868. [DOI] [PubMed] [Google Scholar]; (b) Gallo RC; Salahuddin SZ Popovic M; Shearer GM; Kaplan M; Haynes BF; Palker TJ; Redfield R; Oleske J; Safai B; White G; Foster P; Markham PD Science 1984,224,500. [DOI] [PubMed] [Google Scholar]
- (2).(a) Kramer RA; Schaber MD; Skalka AM; Ganguly K; Wong-Staal F; Reddy EP Science 1986,231,1580. [DOI] [PubMed] [Google Scholar]; (b) Dunn BM; Kay JJ Anti. Chem 1990, 1, 3. [Google Scholar]
- (3).Kohl NE; Emini EA,; Schleif WA,; Davis LJ; Heimbach JC; Dixon RAF; Scolnick EM; Sigal IS Proc. Natl. Acad. Sci. U.S.A. 1988,85,4686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (4).(a) Sigal IS; Huff JR; Darke PL; Vacca JP; Young SD; desolms JS; Thompson WJ; Lyle TA; Graham SL; Ghosh A K. Eur. Pat. Appl 0337714, 1988. [Google Scholar]; (b) Lyle TA,; Wiscount CM; Guare JP; Thompson WJ; Anderson PS; Darke PL; Zugay JA; Emini EA; Schleif WA; Quintero JC; Dixon RAF; Sigal IS; Huff JR J. Med. Chem 1991, 34, 1228 and references cited therein. [DOI] [PubMed] [Google Scholar]
- (5).(a) Dreyer GB; Metcalf BW; Tomaszek TA; Carr TJ; Chandler AC; Hyland L; Fakhoury SA; Magaard VW; Moore ML; Srickler JE; Debouck C; Meek TD proc. Natl. Acad. Sci. U.S.A. 1989, 88, 9752. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) McQuade TJ; Tomasselli AG; Liu L; Karacostas V; Moss B; Sawyer TK; Heinrickson RL; Tarpley WG Science 1990, 247, 454. [DOI] [PubMed] [Google Scholar]; (c) Roberts NA; Martin JA; Kinchington D; Broadhunt AV; Craig JC; Duncan IB; Galpin SA; Handa BK; Kay J; Krohn A; Lambert RW; Merrett JH; Mills JS; Parkes KEB; Redshaw S; Ritchie AJ; Taylor DL; Thomas GJ; Machin PJ Science 1990, 248, 358. [DOI] [PubMed] [Google Scholar]; (d) Ashorn P; McQuade TJ; Thaisrivonge S; Tomasselli AG; Tarpley WG; Moss B Proc. Natl. Acad. Sci. U.S.A. 1990,87, 7472 and references cited therein. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (6).(a) Pauling L Chem. Eng. .News 1946, 24, 1375. [Google Scholar]; (b) Wolfenden R Nature 1969, 223, 704. [DOI] [PubMed] [Google Scholar]; (c) Marciniszyn J; Hartsuck J; Tang JJ Biol. Chem 1976, 251, 7088. [PubMed] [Google Scholar]
- (7).(a) Niahi T; Kitamura M; Ohkuma T; Noyori R Tetrahedron Lett. 1988, 29, 6327. [Google Scholar]; (b) Bemardi A; Micheli F; Potenza D; Scolaatico C; Villa R Tetrahedron Lett. 1990, 31, 4949 and references cited therein. [Google Scholar]
- (8).(a) Szelke M; Jones DM; Atrash B; Hallett A; Leckie B J. Proc. Am. Pept. Symp. 8th 1983,579. [Google Scholar]; (b) Leckie BJ; Grant J; Hallett A; Hughes M; Jones DM; Szelke M; Tree M Scott. Med. J. 1984, 29, 125. [PubMed] [Google Scholar]
- (9).(a) Rich DH; Salituro FG; Holliday MW hoc. Am. Pept. Symp. 8th 1983,511. [Google Scholar]; (b) Holliday MW; Rich RH Tetrahedron Lett. 1983, 24, 4401. [Google Scholar]
- (10).Greenlee WJ J. Med. Res. Rev 1990, 10, 173 and references cited therein. [DOI] [PubMed] [Google Scholar]
- (11).(a) Acid proteases: Structure, Function, and Biology; Tang J, Ed.; Plenum: New York, 1977. [Google Scholar]; (b) Peach, M. J. Physiol. Rev. 1977, 57, 313. [DOI] [PubMed] [Google Scholar]
- (12).(a) Evans BE; Rittle KE: Homnick CF: Sarinner d. P.: Hirshfeld J: Veber DF J. Org. Chem 1985, 50, 4615. [Google Scholar]; (b) Fray AH; Kaye RL; Kleinman EF J. Org. Chem 1986, 51, 4828. [Google Scholar]; (c) Kempf DJ J. Org. Chem 1986, 51 3921. [Google Scholar]; (d) Bradbury RH; Revill JM; Rivett JE; Waterson D Tetrahedron Lett. 1989, 30, 3845. [Google Scholar]; (e) Herold P; Duthaler R; Rihs G; Angst CJ Org. Chem 1989,54, 1178 [Google Scholar]; (f) Chakravarty PK; de Laszlo SE; Sarnella CS; Springer JP; Schude PF Tetrahedron Lett. 1989, 30, 415. [Google Scholar]
- (13).Freudenberg K; Wolf A Ber. 1927,60, 232. [Google Scholar]
- (14).(a) Ireland RE; Thaisrivongs S; Vanier N; Wilcox CS J. Org. Chem 1980,45,48. [Google Scholar]; (b) Ireland RE; Norbeck DW; Mandel GS; Mandel NS J. Am. Chem. SOC 1985, 107, 3285. [Google Scholar]
- (15).(a) Ferrier RJ; J. Chem. SOC 1964, 5443. [Google Scholar]; (b) Ferrier RJ; Prasad NJ Chem. SOC. C 1969, 570. [Google Scholar]
- (16).(a) Lemieux RU Pure Appl. Chem 1971,27,527. [Google Scholar]; (b) Zefirov NS; Shekhtman NM Russ. Chem. Reu 1971, 40, 315. [Google Scholar]
- (17).(a) Lal B; Pramanik BN; Manhas MS; Bose AK; Tetrahedron Lett. 1977, 23, 1977. [Google Scholar]; (b) Shioiri T; Ninomiya K; Yamada s.; J. Am. Chem. SOC. 1972,94,6203. [DOI] [PubMed] [Google Scholar]; (c) Mitsunobu O; Synthesis 1981, 1. [Google Scholar]
- (18).Grieco PA; Oguri T; Yokoyama Y Tetrahedron Lett. 1978, 419. [Google Scholar]
- (19).(a) Maaahiro S; Hori K; Ohfune Y Tetrahedron Lett. 1988,29, 2983. [Google Scholar]; (b) Saito S; Nakajima H; Inaba M; Moriwake T Tetrahedron Lett. 1989, 30, 837. [Google Scholar]
- (20).Basha A; Lipton M; Weinreb SM Tetrahedron Lett. 1977, 4171. [Google Scholar]
- (21).All new compounda gave satisfactory spectroscopic and analytical results.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


